Johnson & Johnson says it is delaying rollout of its COVID vaccine in Europe amid blood clot reports
Johnson & Johnson says it is delaying rollout of its COVID vaccine in Europe amid blood clot reports

Johnson & Johnson will delay the rollout of their COVID-19 vaccine in Europe following reports of blood clots in six people after receiving jab.